Bayer Healthcare to provide over 600,000 moxifloxacin tablets to fight MDR-TB in China

Aug 17 2011

Bayer Healthcare announced on Monday it "has agreed to support the World Health Organization (WHO) and the Stop TB Partnership in the fight against multidrug-resistant tuberculosis (MDR-TB) by making 620,000 tablets of the antibiotic moxifloxacin available to WHO," according to a Bayer press release. The WHO will provide the antibiotics to China's national TB program through the Stop TB Partnership's Global Drug Facility, the release states (8/15).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Disease/Infection News | Healthcare News | Pharmaceutical News

Tags: , , , ,

Comments (0)

Suggested Reading

SUSA initiative aims to equip healthcare professionals with digital skills
Study reveals AI's potential and pitfalls in medical diagnosis
UK's drug payment disclosure system fails to protect patients and public trust
UiA leads project to integrate robots into healthcare services
Digital consultations not reliable for tonsillitis assessment
Study highlights disparities in stroke costs across healthcare services in Latin America
Could medical imaging innovation be the catalyst for precision medicine?
From potential to practice: A blueprint for responsible AI in healthcare

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Survey reveals strong public desire for notification about AI use in healthcare